Answer
The selected product is licensed for neurogenic detrusor overactivity from age 3 to under 18 years. Its safety and efficacy for ordinary overactive bladder have not been established in people under 18.
Sources for this answer
- Mirabegron Astellas 25mg & 50mg prolonged-release tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.